(VIANEWS) – SWORD GROUP (SWP.PA), RUBIS (RUI.PA), FRØY (FROY.OL) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio so far. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. SWORD GROUP (SWP.PA)
86.88% Payout Ratio
Sword Group S.E. provides IT and digital transformation services in Europe, the United States, the Oceania, and Asia. The company provides information systems integration and engineering services, including strategic and operational consulting, solution engineering and application development, project ownership support and project management support, infrastructure management and application maintenance for third parties, and resource outsourcing. Its products include Sword Phusion, an engineering information management software; Sword Tell, a CAD software for watch manufacturers and other industry sectors; Sword Venue, an event planning, collaboration, and organization software; and Sword Aequos that helps organizations to focus on their main business by implementing optimal collaborative tools and solutions supporting their day-to-day reality. The company serves banking and insurance, finance, industry, energy, public services, health, telco, government, and other markets. Sword Group S.E. was founded in 2000 and is headquartered in Windhof, Luxembourg.
Earnings Per Share
As for profitability, SWORD GROUP has a trailing twelve months EPS of €11.4.
PE Ratio
SWORD GROUP has a trailing twelve months price to earnings ratio of 3.61. Meaning, the purchaser of the share is investing €3.61 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 112.09%.
Moving Average
SWORD GROUP’s worth is below its 50-day moving average of €41.69 and under its 200-day moving average of €41.69.
Yearly Top and Bottom Value
SWORD GROUP’s stock is valued at €41.10 at 07:10 EST, way under its 52-week high of €53.00 and way higher than its 52-week low of €35.50.
Revenue Growth
Year-on-year quarterly revenue growth grew by 21.3%, now sitting on 272.26M for the twelve trailing months.
More news about SWORD GROUP.
2. RUBIS (RUI.PA)
72.94% Payout Ratio
Rubis engages in the operation of bulk liquid storage facilities for commercial and industrial customers in Europe, Africa, and the Caribbean. The company operates through Retail & Marketing, Support & Services, and Renewable Electricity production segments. It operates terminals that provide bulk liquid storage facilities for fuels, chemicals, and agri-food products; and distributes fuels, liquefied gases, bitumen, and lubricants. The company also provides infrastructure, transportation, supply, and services for supporting the development of downstream distribution and marketing activities; and produces photovoltaic electricity. Rubis was incorporated in 1954 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, RUBIS has a trailing twelve months EPS of €2.52.
PE Ratio
RUBIS has a trailing twelve months price to earnings ratio of 8.79. Meaning, the purchaser of the share is investing €8.79 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.72%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 51.5%, now sitting on 7.13B for the twelve trailing months.
Moving Average
RUBIS’s value is way under its 50-day moving average of €25.63 and way under its 200-day moving average of €24.65.
Yearly Top and Bottom Value
RUBIS’s stock is valued at €22.16 at 07:10 EST, way below its 52-week high of €27.14 and higher than its 52-week low of €20.74.
More news about RUBIS.
3. FRØY (FROY.OL)
57.92% Payout Ratio
Frøy ASA provides integrated service to the aquaculture industry in Norway. The company offers wellboat services, sea freight, de-lice and treatment, mooring and laying, ring washing and cage services, inspection and certification, bottom mapping and documentation, tow, and ROV and diving services, as well as drainage, inspection, and repair services. It owns and operates 19 wellboats, 64 aqua service vessels, and 3 feed transport vessels. The company was founded in 2019 and is headquartered in Sistranda, Norway.
Earnings Per Share
As for profitability, FRØY has a trailing twelve months EPS of kr2.59.
PE Ratio
FRØY has a trailing twelve months price to earnings ratio of 29.11. Meaning, the purchaser of the share is investing kr29.11 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.67%.
Yearly Top and Bottom Value
FRØY’s stock is valued at kr75.40 at 07:10 EST, under its 52-week high of kr76.00 and way above its 52-week low of kr31.70.
More news about FRØY.
4. SPAREBANK 1 SMN (MING.OL)
55.36% Payout Ratio
SpareBank 1 SMN, together with its subsidiaries, provides various banking, accounting, and real estate products and services to private individuals and companies in Norway and internationally. The company offers mortgage, car, boat, other vehicles, and consumer loans; refinancing; and current, savings, billing, business, group, tax deduction, currency, and deposit accounts. It also provides BSU house savings for young people; fixed interest deposits; stocks and investments; cash services; and payments. In addition, the company offers vehicle, housing and travel, person, animal, and valuables insurance services; property buying and selling advisory services; and mobile and online banking, and various cards. Further, it offers loans and financing, including bank guarantees, business and construction loans, operating credit for agriculture, factoring, guarantees, leasing, and overdrafts; various pension products; and business and personal insurance products. Additionally, the company provides document collection, letter of credit, future business, and currency option services; and services, including accounting and payroll, HR, taxes and duties, and transfer of ownership, as well as IT solutions. It offers real estate agency, advisory, and external and equity financing services. SpareBank 1 SMN was founded in 1823 and is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, SPAREBANK 1 SMN has a trailing twelve months EPS of kr11.67.
PE Ratio
SPAREBANK 1 SMN has a trailing twelve months price to earnings ratio of 12.1. Meaning, the purchaser of the share is investing kr12.1 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.31%.
Yearly Top and Bottom Value
SPAREBANK 1 SMN’s stock is valued at kr141.20 at 07:10 EST, above its 52-week high of kr139.00.
Revenue Growth
Year-on-year quarterly revenue growth declined by 2.6%, now sitting on 6.1B for the twelve trailing months.
Volume
Today’s last reported volume for SPAREBANK 1 SMN is 90035 which is 38.94% below its average volume of 147460.
Sales Growth
SPAREBANK 1 SMN’s sales growth is 22.7% for the current quarter and 20% for the next.
More news about SPAREBANK 1 SMN.
5. Coca-ColaEuropacif (CCEP.AS)
51.06% Payout Ratio
Coca-Cola Europacific Partners PLC, together with its subsidiaries, produces, distributes, and sells a range of non-alcoholic ready to drink beverages. It offers flavours, mixers, and energy drinks; soft drinks, waters, enhanced water, and isotonic drinks; and ready-to-drink tea and coffee, juices, and other drinks. The company provides its products under the Coca-Cola, Diet Coke, Coca-Cola Zero Sugar, Fanta, Sprite, Monster Energy, Coca-Cola Energy, Relentless, nalu, URGE, BURN, Kuli, REIGN, POWERADE, Appletiser, Schweppes, FINLEY, mezzo mix, Royal Bliss, Lift, Vio SCHORLE, Coca-Cola Signature Mixers, NORDIC MIST, smartwater, Chaudfontaine, AQUARIUS, VILAS del Turbon, BONAQUA, Apollinaris, Krystal, Honest, Costa Coffee, Fuzetea, CHAQWA, NESTEA, Capri-Sun, Oasis, Minute Maid, MER, and Tropico brands. In addition, it engages in the bottling and other operations. The company was formerly known as Coca-Cola European Partners plc and changed its name to Coca-Cola Europacific Partners PLC in May 2021. Coca-Cola Europacific Partners PLC was founded in 1904 and is based in Uxbridge, the United Kingdom.
Earnings Per Share
As for profitability, Coca-ColaEuropacif has a trailing twelve months EPS of €3.29.
PE Ratio
Coca-ColaEuropacif has a trailing twelve months price to earnings ratio of 17.93. Meaning, the purchaser of the share is investing €17.93 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.75%.
More news about Coca-ColaEuropacif.
6. TUBIZE-FIN (TUB.BR)
39.2% Payout Ratio
Financière de Tubize SA, through its interest in UCB, operates as a biopharmaceutical company worldwide. It discovers and develops medicines and solutions in the therapeutic areas of neurology and immunology diseases. The company's products include Cimzia for treating ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Briviact, Vimpat, and Keppra for the treatment of epilepsy partial-onset seizures; Nayzilam, a nasal spray; and Neupro for treating Parkinson's disease and restless legs syndrome. It also offers Evenity, an injection for osteoporosis; and Bimzelx to treat moderate to severe plaque psoriasis. The company's products in pipeline include Staccato to treat stereotypical prolonged seizures; Bepranemab for the treatment of Alzheimer's disease; UCB0599 for Parkinson's disease; bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, myelin oligodendrocyte glycoprotein antibody disease, and autoimmune encephalitis; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize SA is based in Brussels, Belgium.
Earnings Per Share
As for profitability, TUBIZE-FIN has a trailing twelve months EPS of €1.92.
PE Ratio
TUBIZE-FIN has a trailing twelve months price to earnings ratio of 36.41. Meaning, the purchaser of the share is investing €36.41 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.93%.
More news about TUBIZE-FIN.
